Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Trips WAIVER protest outside Belgium embassy in South Africa Photograph by Karabo Shai
Press release
Press release |
15 October 2021
COVID-19

MSF responds to another misleading attempt by EU to undermine TRIPS Waiver

4 min
The GeneXpert machine can identify the bacteria responsabile for tuberculosis (Mycobacterium tuberculosis) and also drug resistance. Photograph by Pierre-Yves Bernard
Press release
Press release |
14 October 2021
COVID-19

MSF warns of deadly TB testing gap following release of WHO Global TB Report 2021

4 min
South Africa TRIPS waiver protest in front of Netherlands embassy Photograph by Candice Sehoma
Press release
Press release |
12 October 2021
COVID-19

As time runs out to break ‘TRIPS Waiver’ stalemate, protesters at US and EU embassies in South Africa warn “The whole world is watching you.”

5 min
Doctor Banza Ilunga, clinical doctor at the COVID19 Treatment Center (CTCO) housed by the Referral Kinkole Hospital (HGR), takes care of hospitalized patients in this establishment on the downtown of Kinshasa, the capital of the Democratic Republic of the Congo (DRC). Photograph by Charly Kasereka
Press release
Press release |
11 October 2021
COVID-19

MSF responds to news of Merck filing for US FDA Emergency Use Authorization for the potential oral COVID-19 treatment molnupiravir

3 min
Aboo Abdul is a 45-year-old man from Syria who suffers from diabetes. Due to the war and his medical condition he decided take his family to Greece. Photograph by Enri Canaj
Press release
Press release |
01 October 2021
Diabetes

MSF responds to inclusion of insulin analogues to the WHO’s Essential Medicines List

3 min
Members of various civil societies gathered outside the embassies of the United States, United Kingdom, Australia, Canada, Brazil, and other countries which opposed a temporary patent waiver on COVID-19 vaccines which was proposed to the World Trade Organization by South Africa and India. Photograph by Tadeu Andre
Press release
Press release |
01 October 2021
COVID-19

One year on from the landmark “TRIPS Waiver” proposal, a small minority of governments continue to block the will of the majority of the world

3 min
COVID-19 wards and COVID-19 suspect wards are also acute internal medicine wards, where there are a range of comorbidities to be managed. Photograph by Chris Allan
Press release
Press release |
30 September 2021
COVID-19

MSF urges Sanofi to hand over abandoned mRNA vaccine candidate to WHO mRNA vaccine tech transfer hub in South Africa

5 min
MSF's medical team visited Ana and Marcos de Oliveira at their home in the Grande Bom Jardim territory, Fortaleza, a few days after they tested positive for COVID-19 in one of our mobile clinics. Photograph by Mariana Abdalla
Press release
Press release |
24 September 2021
COVID-19

Newest COVID-19 treatment recommended by WHO must be made accessible to everyone who needs it

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury